P Perez Selected Research

Activated Protein C Resistance (APC Resistance)

10/2001	Sensitivity of the ProC global assay for protein C pathway abnormalities. clinical experience in 899 unselected patients with venous thromboembolism.
4/2000	Screening for risk factors for thrombosis using a new generation of assays developed to evaluate the functionality of the protein C anticoagulant pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P Perez Research Topics

Disease

3	Neoplasms (Cancer) 05/2018 - 01/2017
2	Infections 01/2022 - 01/2017
2	Shock 07/2015 - 12/2010
2	Thrombophilia 10/2001 - 04/2000
2	Activated Protein C Resistance (APC Resistance) 10/2001 - 04/2000
1	Persistent Infection 01/2022
1	Sialadenitis 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Mucoepidermoid Carcinoma 05/2018
1	Pheochromocytoma 05/2018
1	Neoplasm Metastasis (Metastasis) 07/2017
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2017
1	Multiple Organ Failure (MODS) 07/2015
1	acquired Thrombotic thrombocytopenic purpura 02/2015
1	Thrombotic Thrombocytopenic Purpura 02/2015
1	Thrombotic Microangiopathies 02/2015
1	Coinfection 01/2014
1	Critical Illness (Critically Ill) 09/2013
1	Cardiogenic Shock 09/2013
1	Hypoparathyroidism 01/2011
1	Hypotension (Low Blood Pressure) 12/2010
1	Vasoplegia 12/2010
1	Sepsis (Septicemia) 12/2010
1	Crohn Disease (Crohn's Disease) 08/2009
1	Bacterial Infections (Bacterial Infection) 06/2007
1	Phototoxic Dermatitis (Phototoxicity) 09/2006
1	Liver Failure 10/2001
1	Venous Thromboembolism 08/2001
1	Pancytopenia 07/2001
1	Protein C Deficiency 04/2000
1	Protein S Deficiency (Deficiency, Protein S) 04/2000
1	Thrombosis (Thrombus) 04/2000

Drug/Important Bio-Agent (IBA)

4	Protein CIBA 12/2010 - 04/2000
2	AnticoagulantsIBA 10/2001 - 04/2000
2	factor V LeidenIBA 10/2001 - 04/2000
1	RNA (Ribonucleic Acid)IBA 01/2022
1	AutoantibodiesIBA 01/2022
1	MetanephrineIBA 05/2018
1	MicroRNAs (MicroRNA)IBA 05/2018
1	Biological ProductsIBA 05/2018
1	Oxygen (Dioxygen)IBA 01/2017
1	thiamine triphosphorate (TTP)IBA 02/2015
1	Troponin IIBA 02/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2013
1	Hormones (Hormone)IBA 01/2011
1	CalciumIBA 01/2011
1	CatecholaminesIBA 12/2010
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 12/2010
1	Vasoconstrictor AgentsIBA 12/2010
1	Vasopressins (Vasopressin)IBA 12/2010
1	Adenosine Triphosphate (ATP)IBA 12/2010
1	Peroxynitrous Acid (Peroxynitrite)IBA 12/2010
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2010
1	GlucocorticoidsIBA 12/2010
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2010
1	TerlipressinIBA 12/2010
1	DNA (Deoxyribonucleic Acid)IBA 08/2009
1	ProcalcitoninIBA 06/2007
1	Methoxsalen (Oxsoralen)FDA Link 09/2006
1	Ketoprofen (Orudis)FDA LinkGeneric 09/2006
1	Chlorpromazine (Thorazine)FDA Link 09/2006
1	Factor V (Coagulation Factor V)IBA 10/2001
1	Biomarkers (Surrogate Marker)IBA 04/2000
1	Factor VIII (Coagulation Factor VIII)IBA 04/2000
1	Protein SIBA 04/2000

Therapy/Procedure

2	Therapeutics 01/2011 - 12/2010
1	Electrodes (Electrode) 07/2017
1	Noninvasive Ventilation 01/2017
1	Aftercare (After-Treatment) 07/2015
1	Controlled Hypotension 12/2010
1	Platelet Transfusion (Blood Platelet Transfusions) 07/2001